Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Augere Medical set a precedent in 2024 by becoming one of the first companies to secure MDR CE marking for an AI-driven polyp detection system called PolypAID. This globally recognised milestone marks the culmination of a decade-long pursuit sparked by a visionary question in 2014; Could artificial intelligence revolutionise colonoscopy screenings to enhance polyp detection? The question did not originate in a boardroom but during a meeting of minds. Professor Michael Riegler, a computer scientist at Simula Research Laboratories, approached Dr. Thomas de Lange, a clinician at Bærum Hospital near Oslo, with an idea to merge technical innovation and clinical practice. The conversation soon evolved into a mission to reimagine the intersection of medicine and technology in the service of saving lives. “At the time, two seemingly unrelated projects were underway; using AI to analyse football matches and exploring polyp detection,” recalls Jon H. Hoem, Executive Chair. “While the value propositions couldn’t have been more distinct, they converged in a shared ambition to push AI’s boundaries.” By 2018, this vision had taken shape as Augere Medical (Augere; Latin for “growth”), a company founded on collaboration and driven by the singular purpose of advancing patient care through cutting-edge technology.
requirements driven by FDA recommendations and new standards and guidelines. The new guidelines recommend moving to sterilization for high-risk scopes such as bronchoscopes, duodenoscopes, ureteroscopes, and cystoscopes. This makes reprocessing more timeconsuming and expensive, and due to staff shortages and higher staff turnover, maintaining compliance also becomes a cumbersome affair. Enter Ambu A/S. By providing a single-use option, Ambu helps customers improve their workflow, efficiency, and productivity for better patient care while eliminating the risk of cross-contamination. The company creates flexibility for customers to structure care delivery and procedure scheduling much more efficiently by eliminating the need for reprocessing.
In the fast-paced and continually advancing field of medical technology, Prosidio distinguishes itself as an innovator. The company has revolutionized patient care with the creation of all-in-one camera systems, an ideal fit for clinics and ambulatory surgical centers. These breakthrough systems merge vital components, including the light source, camera, image processor, and monitor into a singular, seamless device. This singular solution expedites endoscopic procedures and places Prosidio in a unique position, alongside Karl Storz as one of the few major providers offering such a holistic solution. Their comprehensive camera systems have gained widespread acclaim within the medical fraternity. By integrating crucial elements into a single device, Prosidio simplifies setups, eliminating the need for multiple devices. This consolidation enhances convenience, streamlines workflow, and delivers significant cost savings for healthcare institutions. The benefits are particularly noteworthy for clinics and smaller ambulatory surgical centers, where space and resources can often be constrained.
Colonoscopy Guidance System
Novuroze Fazal, Head of Clinical Engineering, West Hertfordshire Teaching Hospitals NHS Trust
Colonoscopy Guidance System
Anne Mary K. Montero, Medical Director, Indiana University Health
Endoscopy
Professor Paul Dimitri, Director of Research and Innovation, Sheffield Children’s NHS Foundation Trust
ENT Devices
Kevin Watson, MD, FAAP, Assistant Director Clinical Informatics - Specialty Systems, Akron Children’s Hospital
Colonoscopy Guidance System
Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN, Manager of Gastroenterology Advanced Practice Provider Services at UChicago Medicine
Europe's colonoscopy guidance systems sector is undergoing rapid advancements fueled by technological innovations, the rising demand for minimally invasive procedures, and the increasing prevalence of colorectal cancer (CRC).
The field of gastroenterology is undergoing a transformative shift driven by innovations in colonoscopy guidance technology.
A Giant Leap towards Reducing the Global Burden of Colorectal Cancer
The global medical devices market was valued at USD 562.6 billion in 2024 and is expected to grow at a CAGR of 6.2 percent during the forecast period of 2025-2034 and reach a market value of USD 965.2 billion by 2034. From navigating the complexities of FDA submissions in the U.S. to achieving CE markings in Europe, regulatory pathways are pivotal in ensuring that innovative medical technologies meet the highest safety and efficacy standards. This environment underscores the indispensable role of regulatory consulting firms, which provide the expertise needed to navigate these challenges efficiently.
This edition of MedTech Outlook spotlights Advena as the Medical Devices Regulatory Consulting Company of the Year in UK 2025. Advena specialises in providing regulatory consulting services for small—to medium-sized businesses in the medical technology sector. The company also focuses on tailored, cost-effective solutions that help clients navigate complex regulatory environments, ensuring compliance and successful market entry for their innovative medical devices.
The publication also features thought leadership articles from key opinion leaders. One of them, Eric Huang, Engineering Manager, Alcon, emphasizes the importance of challenging established rules in medical device manufacturing and highlights the potential to improve device quality, production yield and innovation through collaboration and courage. The issue also features insights from Patty Ryan, Sr. Director, Chief Information Security Officer of QuidelOrtho, who underscores the transformative role of AI in information security and its potential for threat detection, secure development and data protection.
We also spotlight pioneering companies that have embraced regulatory consulting to achieve remarkable milestones. From wearable health monitors gaining fast-track approval to AI-powered diagnostic tools navigating stringent global standards, these success stories highlight the transformative impact of expert regulatory guidance in advancing healthcare innovation.
We hope this edition inspires you to explore the possibilities in this everevolving device regulatory consulting domain. Let us know your thoughts!
